Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2020 Sep 25;10(1):15793.
doi: 10.1038/s41598-020-72597-0.

There is a cycle to cycle variation in ovarian response and pre-hCG serum progesterone level: an analysis of 244 consecutive IVF cycles

Affiliations
Clinical Trial

There is a cycle to cycle variation in ovarian response and pre-hCG serum progesterone level: an analysis of 244 consecutive IVF cycles

Sule Yildiz et al. Sci Rep. .

Abstract

We aimed to answer one key question, that was not previously addressed as to whether serum progesterone (P4-hCG day) and its co-variates (estradiol (E2-hCG day) and the number of retrieved oocytes) of a given cycle can be predictive of the subsequent cycle when both cycles are consecutive and comparable for the stimulation protocol, gonadotropin dose and duration of stimulation. We analyzed such 244 consecutive (< 6 months) IVF cycles in 122 patients with GnRH agonist long protocol and found that P4, E2 and the number of retrieved oocytes significantly vary between the two cycles. Although P4 increased (ranging from 4.7 to 266.7%) in the 2nd cycle in 61 patients, E2 and the number of retrieved oocytes, which are normally positively correlated with P4 paradoxically decreased in the 41% and 37.7% respectively, of these same 61 patients. When a similar analysis was done in the 54 out of 122 patients (44.3%) in whom serum P4 was decreased in the 2nd cycle, the mean decrease in P4 was - 34.1 ± 23.3% ranging from - 5.26 to - 90.1%. E2 and the number of retrieved oocytes paradoxically increased in the 42.3% and 40.7% of these 54 patients respectively. P4 remained the same only in the 7 (5.7%) of these 122 patients. These findings indicate that late follicular phase serum P4 may change unpredictably in the subsequent IVF cycle. The changes are not always necessarily proportional with ovarian response of previous cycle suggesting that growth characteristics and steroidogenic activities of antral cohorts may exhibit considerable cycle to cycle variations.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
The association of P4 level on the hCG day with E2 level on the hCG day, and the numbers of fol > 14 mm and retrieved oocytes on the correlation and linear regression analyses in the 1st and 2nd IVF cycles.
Figure 2
Figure 2
Comparison of the means of P4 on the hCG day (A) and its co-variates E2 on the hCG day (B), and the numbers of fol > 14 mm on day 10 of stimulation (C) and retrieved oocytes (D) between the 1st and 2nd IVF cycles are shown as scatter plot with bars (the left images graphics). The variations in these parameters between the cycles are also shown as lines (the right graphics).
Figure 3
Figure 3
Scatter plot diagrams of the percent changes of P4 on the hCG day and its correlates E2 on the hCG day, and the numbers of fol > 14 mm on day 10 of stimulation and retrieved oocytes overall (A), and when P4 in the second cycle is > 0 (B), < 0 (C) or = 0 (D). Paradoxical changes in the co-variates of P4 (Y-axis) when P4 increased and decreased are visible on the X-axis.
Figure 4
Figure 4
Histogram depiction of the percent change of P4 in the 2nd cycle (x-axis) and the corresponding percent change in E2, and the numbers of fol > 14 mm and retrieved oocytes (y-axis). Light green areas show the cycles in which there are parallel changes in P4 and its co-variates (E2 and the numbers of fol > 14 mm and retrieved oocytes). Light blue areas demonstrate the cycles in which there were paradoxical changes in P4 and its correlates. Solid line: linear regression, dotted line 95% confidence intervals.

Similar articles

Cited by

References

    1. Venetis CA, Kolibianakis EM, Bosdou JK, Tarlatzis BC. Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles. Hum. Reprod. Update. 2013;19:433–457. doi: 10.1093/humupd/dmt014. - DOI - PubMed
    1. Martinez F, et al. Should progesterone on the human chorionic gonadotropin day still be measured? Fertil. Steril. 2016;105:86–92. doi: 10.1016/j.fertnstert.2015.09.008. - DOI - PubMed
    1. Urman B, et al. Elevated serum progesterone level on the day of human chorionic gonadotropin administration does not adversely affect implantation rates after intracytoplasmic sperm injection and embryo transfer. Fertil. Steril. 1999;72:975–979. doi: 10.1016/S0015-0282(99)00421-5. - DOI - PubMed
    1. Venetis CA, et al. Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles. Hum. Reprod. 2015;30:684–691. doi: 10.1093/humrep/deu362. - DOI - PubMed
    1. Griesinger G, et al. Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trials. Fertil. Steril. 2013;100(1622–1628):e1621–1623. doi: 10.1016/j.fertnstert.2013.08.045. - DOI - PubMed

Publication types

Substances